Τετάρτη 31 Αυγούστου 2016

Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy

Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy

Molecular Therapy 24, 1378 (August 2016). doi:10.1038/mt.2016.97

Authors: Yuanzheng Gao, Xiuming Guo, Katherine Santostefano, Yanlin Wang, Tammy Reid, Desmond Zeng, Naohiro Terada, Tetsuo Ashizawa & Guangbin Xia



from Cancer via ola Kala on Inoreader http://ift.tt/2cr49wI
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου